发明名称 CHEMICAL COMPOUNDS
摘要 22008 CHEMICAL COMPOUNDS Compounds of the formula (1) : (1) and pharmaceutically acceptable salts are described, wherein X is O or S; R1 is C1-6alkyl, C2-6alkenyl, C3-5cycloalkylC1-4 alkyl, or C1-4alkyl substituted by 1 to 3 fluoro groups; R2 is hydrogen, -CN, -CONR5R6, -CO2R7, 5-tetrazolyl, -NO2, -NH2 or -NHCOR8 wherein R5 to R8 are independently hydrogen or C1-4alkyl; R3 is hydrogen or C1-4alkyl; R4 is hydrogen or C1-4alkyl; and R is halo, C1-4alkyl, C1-4alkoxy, cyano, -CONR9R10, -CO2R11, -S(O)nC1-4alkyl, -NO2, -NH2, -NHCOR12, or -SO2NR13R14 wherein n is 0, 1 or 2 and R9 to R14 are independently hydrogen or C1-4alkyl; with the proviso that R1 is not methyl when R2 is -CO2H, -CO2CH2CH3 or -CN, X is 0, R3 is hydrogen, R4 is hydrogen or methyl and R is 6-methoxy. These compounds have bronchodilator, anti-allergic, vasodilator and anti-inflammatory activities. Pharmaceutical compositions are described as are methods of use. Processes for the preparation of the compounds of the formula (1) are described.
申请公布号 CA2027169(A1) 申请公布日期 1991.04.14
申请号 CA19902027169 申请日期 1990.10.09
申请人 SMITH KLINE & FRENCH LABORATORIES LIMITED 发明人 COATES, WILLIAM J.;FLYNN, SEAN T.
分类号 A61K31/41;A61K31/44;A61K31/4402;A61K31/4418;A61K31/4427;A61P9/08;A61P9/10;A61P9/12;A61P11/08;A61P37/08;C07C45/61;C07C49/76;C07C49/84;C07C255/19;C07D213/64;C07D213/70;C07D213/72;C07D213/78;C07D213/80;C07D213/82;C07D213/85;C07D401/04;(IPC1-7):C07D213/60 主分类号 A61K31/41
代理机构 代理人
主权项
地址